Abstract
The data we obtained point to the need to further investigate the polymorphic loci we selected in a larger patient sample, which will enable using this genetic marker in the future as the assessment criterion in the individual outlook of preeclampsia development in GDM pregnant women to take efficient preventive measures to timely remedy and improve the pregnancy outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have